透析服務市場 - 按類型（血液透析、腹膜透析）、按服務（急性透析、慢性透析）、最終用途（中心透析、居家透析）和預測，2024 - 2032 年

受慢性腎臟病 CKD 盛行率不斷上升的推動，人口老化和生活方式相關疾病加劇了這一趨勢，2024 年至 2032 年，全球透析服務市場的複合年成長率將超過 5.1%。根據美國國家糖尿病、消化和腎臟疾病研究所NIDDKD的最新資料，2021年，美國約有78.6萬人被診斷出患有末期腎病ESRD，其中71%正在接受透析治療。

隨著慢性腎臟病發生率的上升，對透析服務的需求也隨之激增。這種成長是由於患有末期腎臟病 ESRD 和其他腎臟相關併發症的患者對維持生命治療的需求所推動的。醫療保健系統在滿足這一需求方面面臨著越來越大的挑戰，這促使透析技術和服務提供模式不斷進步，以滿足不斷成長的需要定期和專業護理的患者群體。

整個透析服務市場根據類型、服務、最終用途和地區進行分類。

腹膜透析領域將在 2024 年至 2032 年間保持顯著的複合年成長率。在全球健康挑戰中，這種便利性尤其有吸引力。此外，技術的進步提高了腹膜透析的有效性和安全性，使其成為更多患者的可行選擇。隨著人們對其益處的認知不斷增強，以及醫療保健系統尋求具有成本效益的解決方案，腹膜透析越來越被視為治療慢性腎臟病的傳統血液透析的更佳替代方案。

到 2032 年，急性透析領域將獲得重要的透析服務市場佔有率。由於嚴重感染、手術和危重疾病引起的急性腎損傷 AKI 的發生率不斷增加，急性透析領域正在不斷成長。住院人數的不斷增加以及重症監護病房對即時腎臟支持的需求正在推動對急性透析的需求。此外，急性透析技術的進步和患者治療效果的改善正在鼓勵醫療保健提供者更廣泛地採用這些治療方法。為了滿足緊急醫療需求，急性透析領域正在經歷顯著成長。

由於慢性腎臟病 CKD 和糖尿病人口的迅速增加，到 2032 年，亞太地區透析服務市場將呈現顯著的複合年成長率。經濟發展和城市化正在導致生活方式的改變，從而增加了慢性腎臟病的危險因子。此外，改善的醫療基礎設施和政府加強腎臟護理的措施使透析服務更容易獲得。人們對腎臟健康的認知不斷提高以及先進醫療技術的可用性正在激增這一需求。這些因素共同促進了亞太地區透析服務業的持續擴張。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 末期腎病 (ESRD) 患者數量不斷增加
    • 供腎短缺
    • 提高認知和教育
    • 糖尿病和高血壓的發生率上升
  • 產業陷阱與挑戰
    • 與透析相關的風險和併發症
    • 治療費用高
• 成長潛力分析
• 監管環境
• 技術景觀
• 未來市場趨勢
• 報銷場景
• 波特的分析
• PESTEL分析
• 缺口分析
• 價值鏈分析

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

• 主要趨勢
• 血液透析
• 腹膜透析

第 6 章：市場估計與預測：按服務分類，2021 - 2032 年

• 主要趨勢
• 急性透析
• 慢性透析

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 中心透析
• 居家透析

第 8 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 9 章：公司簡介

• Atlantic Dialysis Management Services, LLC
• Baxter International Inc.
• Centers for Dialysis Care
• DaVita Inc.
• Dialysis Clinic, Inc.
• Diaverum AB
• Fresenius Medical Care
• HATTIESBURG CLINIC
• Innovative Renal Care
• NephroPlus
• Northwest Kidney Centers
• Rogosin Institute
• Sanderling Renal Services
• Satellite Healthcare
• U.S. Renal Care, Inc.

Global Dialysis Services Market will witness over 5.1% CAGR from 2024 to 2032, driven by the escalating prevalence of chronic kidney diseases CKD, a trend amplified by aging populations and lifestyle-related illnesses. According to recent data from the National Institute of Diabetes and Digestive and Kidney Diseases NIDDKD, in 2021, about 786,000 individuals in the United States were diagnosed with End-Stage Renal Disease ESRD, with 71% undergoing dialysis treatment.

As CKD incidence rises, the demand for dialysis services surges correspondingly. This growth is propelled by the need for life-sustaining treatments among patients experiencing End-Stage Renal Disease ESRD and other kidney-related complications. Healthcare systems are increasingly challenged to meet this demand, prompting continuous advancements in dialysis technologies and service delivery models to cater to a growing patient population requiring regular and specialized care.

The overall dialysis services market is classified based on type, service, end-use, and region.

The peritoneal dialysis segment will maintain a notable CAGR between 2024 and 2032. The peritoneal dialysis sector offers patients more flexibility by allowing treatments to be performed at home, reducing the need for frequent hospital visits. This convenience is especially appealing amidst global health challenges. Additionally, advancements in technology have improved the effectiveness and safety of peritoneal dialysis, making it a viable option for more patients. As awareness grows about its benefits and as healthcare systems seek cost-effective solutions, peritoneal dialysis is increasingly viewed as a preferable alternative to traditional hemodialysis for managing chronic kidney disease.

By 2032, the acute dialysis segment will secure a significant dialysis services market share. The acute dialysis segment is rising due to the increasing incidence of acute kidney injuries AKI caused by severe infections, surgeries, and critical illnesses. The growing number of hospitalizations and the need for immediate renal support in intensive care units are driving the demand for acute dialysis. Additionally, advancements in acute dialysis techniques and improved patient outcomes are encouraging healthcare providers to adopt these treatments more widely. The acute dialysis segment is experiencing significant growth in response to urgent medical needs.

Asia Pacific dialysis services market will exhibit a significant CAGR through 2032 due to the rapid increase in the population with chronic kidney disease CKD and diabetes. Economic development and urbanization are contributing to lifestyle changes that heighten CKD risk factors. Additionally, improved healthcare infrastructure and government initiatives to enhance renal care make dialysis services more accessible. The rising awareness about kidney health and the availability of advanced medical technologies are catapulting the demand. These factors collectively contribute to the expanding dialysis services industry in Asia Pacific.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
    • 3.2.1.2 Shortage of donor kidneys
    • 3.2.1.3 Increasing awareness and education
    • 3.2.1.4 Rise in incidence of diabetes and hypertension
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Risks and complications associated with dialysis
    • 3.2.2.2 High treatment costs
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Reimbursement scenario
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 GAP analysis
• 3.11 Value chain analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Hemodialysis
• 5.3 Peritoneal Dialysis

Chapter 6 Market Estimates and Forecast, By Service, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Acute dialysis
• 6.3 Chronic dialysis

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 In-center dialysis
• 7.3 Home dialysis

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Atlantic Dialysis Management Services, LLC
• 9.2 Baxter International Inc.
• 9.3 Centers for Dialysis Care
• 9.4 DaVita Inc.
• 9.5 Dialysis Clinic, Inc.
• 9.6 Diaverum AB
• 9.7 Fresenius Medical Care
• 9.8 HATTIESBURG CLINIC
• 9.9 Innovative Renal Care
• 9.10 NephroPlus
• 9.11 Northwest Kidney Centers
• 9.12 Rogosin Institute
• 9.13 Sanderling Renal Services
• 9.14 Satellite Healthcare
• 9.15 U.S. Renal Care, Inc.